NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 118 filers reported holding NOVAVAX INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,032,073 | -7.3% | 280,673 | +31.7% | 0.01% | -44.4% |
| Q4 2022 | $2,191,326 | -22.1% | 213,164 | +38.0% | 0.01% | -35.7% |
| Q3 2022 | $2,812,000 | -75.8% | 154,510 | -31.5% | 0.01% | -78.5% |
| Q2 2022 | $11,598,000 | +83.5% | 225,518 | +162.9% | 0.06% | +140.7% |
| Q1 2022 | $6,319,000 | -40.5% | 85,793 | +15.5% | 0.03% | -6.9% |
| Q4 2021 | $10,629,000 | -12.5% | 74,284 | +26.8% | 0.03% | -17.1% |
| Q3 2021 | $12,142,000 | -10.0% | 58,569 | -7.9% | 0.04% | -31.4% |
| Q2 2021 | $13,496,000 | +389.7% | 63,570 | +157.2% | 0.05% | +142.9% |
| Q4 2020 | $2,756,000 | -54.8% | 24,714 | -56.1% | 0.02% | -74.4% |
| Q3 2020 | $6,097,000 | +46.6% | 56,271 | +12.7% | 0.08% | +22.4% |
| Q2 2020 | $4,160,000 | +576.4% | 49,910 | +10.3% | 0.07% | +318.8% |
| Q1 2020 | $615,000 | +257.6% | 45,251 | +4.8% | 0.02% | +1500.0% |
| Q4 2019 | $172,000 | – | 43,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |